Literature DB >> 25520004

Aldose Reductase Regulates Microglia/Macrophages Polarization Through the cAMP Response Element-Binding Protein After Spinal Cord Injury in Mice.

Qian Zhang1, Ganlan Bian1, Peng Chen1, Ling Liu1, Caiyong Yu1, Fangfang Liu1, Qian Xue1, Sookja K Chung2, Bing Song3, Gong Ju4, Jian Wang5.   

Abstract

Inflammatory reactions are the most critical pathological processes occurring after spinal cord injury (SCI). Activated microglia/macrophages have either detrimental or beneficial effects on neural regeneration based on their functional polarized M1/M2 subsets. However, the mechanism of microglia/macrophage polarization to M1/M2 at the injured spinal cord environment remains unknown. In this study, wild-type (WT) or aldose reductase (AR)-knockout (KO) mice were subjected to SCI by a spinal crush injury model. The expression pattern of AR, behavior tests for locomotor activity, and lesion size were assessed at between 4 h and 28 days after SCI. We found that the expression of AR is upregulated in microglia/macrophages after SCI in WT mice. In AR KO mice, SCI led to smaller injury lesion areas compared to WT. AR deficiency-induced microglia/macrophages induce the M2 rather than the M1 response and promote locomotion recovery after SCI in mice. In the in vitro experiments, microglia cell lines (N9 or BV2) were treated with the AR inhibitor (ARI) fidarestat. AR inhibition caused 4-hydroxynonenal (HNE) accumulation, which induced the phosphorylation of the cAMP response element-binding protein (CREB) to promote Arg1 expression. KG501, the specific inhibitor of phosphorylated CREB, could cancel the upregulation of Arg1 by ARI or HNE stimulation. Our results suggest that AR works as a switch which can regulate microglia by polarizing cells to either the M1 or the M2 phenotype under M1 stimulation based on its states of activity. We suggest that inhibiting AR may be a promising therapeutic method for SCI in the future.

Entities:  

Keywords:  Aldose reductase; Locomotor recovery; M1/M2 polarization; Microglia/macrophages; Spinal cord injury; cAMP response element-binding protein

Mesh:

Substances:

Year:  2014        PMID: 25520004     DOI: 10.1007/s12035-014-9035-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  54 in total

1.  [The mechanism of the transformation of glucose in fructose in the seminal vesicles].

Authors:  H G HERS
Journal:  Biochim Biophys Acta       Date:  1956-10

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

Review 4.  Repertoire of microglial and macrophage responses after spinal cord injury.

Authors:  Samuel David; Antje Kroner
Journal:  Nat Rev Neurosci       Date:  2011-06-15       Impact factor: 34.870

5.  HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.

Authors:  Jung-Bin Kim; Joon Sig Choi; Young-Mi Yu; Kihoon Nam; Chun-Shu Piao; Seung-Woo Kim; Min-Hyung Lee; Pyung-Lim Han; Jong-Sang Park; Ja-Kyeong Lee
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

6.  Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade.

Authors:  France Vaillancourt; Barbara Morquette; Qin Shi; Hassan Fahmi; Patrick Lavigne; John A Di Battista; Julio C Fernandes; Mohamed Benderdour
Journal:  J Cell Biochem       Date:  2007-04-01       Impact factor: 4.429

7.  Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury.

Authors:  W Xu; L Chi; R Xu; Y Ke; C Luo; J Cai; M Qiu; D Gozal; R Liu
Journal:  Spinal Cord       Date:  2005-04       Impact factor: 2.772

Review 8.  Aldose reductase: a novel therapeutic target for inflammatory pathologies.

Authors:  Kota V Ramana; Satish K Srivastava
Journal:  Int J Biochem Cell Biol       Date:  2009-09-22       Impact factor: 5.085

9.  Tocopherol derivative TFA-12 promotes myelin repair in experimental models of multiple sclerosis.

Authors:  Benoit Blanchard; Tony Heurtaux; Corina Garcia; Natalia M Moll; Céline Caillava; Luc Grandbarbe; Armelle Klosptein; Christophe Kerninon; Magali Frah; Djalil Coowar; Anne Baron-Van Evercooren; Eleonora Morga; Paul Heuschling; Brahim Nait Oumesmar
Journal:  J Neurosci       Date:  2013-07-10       Impact factor: 6.167

10.  Temporal and spatial dynamics of peroxynitrite-induced oxidative damage after spinal cord contusion injury.

Authors:  Kimberly M Carrico; Radhika Vaishnav; Edward D Hall
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

View more
  21 in total

1.  Aldose reductase participates in the downregulation of T cell functions due to suppressor macrophages.

Authors:  Toshiaki Shimizu; Yutaka Tatano; Haruaki Tomioka
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

2.  A Coral-Derived Compound Improves Functional Recovery after Spinal Cord Injury through Its Antiapoptotic and Anti-Inflammatory Effects.

Authors:  Chun-Hong Chen; Nan-Fu Chen; Chien-Wei Feng; Shu-Yu Cheng; Han-Chun Hung; Kuan-Hao Tsui; Chi-Hsin Hsu; Ping-Jyun Sung; Wu-Fu Chen; Zhi-Hong Wen
Journal:  Mar Drugs       Date:  2016-09-02       Impact factor: 5.118

3.  Low-level laser facilitates alternatively activated macrophage/microglia polarization and promotes functional recovery after crush spinal cord injury in rats.

Authors:  Ji Wei Song; Kun Li; Zhuo Wen Liang; Chen Dai; Xue Feng Shen; Yu Ze Gong; Shuang Wang; Xue Yu Hu; Zhe Wang
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

Review 4.  Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases.

Authors:  Gyun Jee Song; Kyoungho Suk
Journal:  Front Aging Neurosci       Date:  2017-05-15       Impact factor: 5.750

Review 5.  NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies.

Authors:  Limin Song; Lei Pei; Shanglong Yao; Yan Wu; You Shang
Journal:  Front Cell Neurosci       Date:  2017-03-09       Impact factor: 5.505

Review 6.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.

Authors:  Yashi Mi; Guoyuan Qi; Roberta Diaz Brinton; Fei Yin
Journal:  Antioxid Redox Signal       Date:  2020-04-21       Impact factor: 8.401

7.  PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord.

Authors:  Binbin Wang; Siyuan Liu; Bingbing Fan; Xingguo Xu; Yonglin Chen; Rongxiang Lu; Zhongling Xu; Xiaojuan Liu
Journal:  J Headache Pain       Date:  2018-01-18       Impact factor: 7.277

8.  Astaxanthin acts via LRP-1 to inhibit inflammation and reverse lipopolysaccharide-induced M1/M2 polarization of microglial cells.

Authors:  Xiaojun Wen; Lijiao Xiao; Zhuoyan Zhong; Limin Wang; Ze Li; Xiaoping Pan; Zhonglin Liu
Journal:  Oncotarget       Date:  2017-09-03

Review 9.  Macrophage polarization: a key event in the secondary phase of acute spinal cord injury.

Authors:  Xiangyi Kong; Jun Gao
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

10.  Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3.

Authors:  Shoubo Chen; Jingfang Ye; Xiangrong Chen; Jinnan Shi; Wenhua Wu; Wenping Lin; Weibin Lin; Yasong Li; Huangde Fu; Shun Li
Journal:  J Neuroinflammation       Date:  2018-05-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.